Gilead Sciences, Inc.
PanVera LLC
Pharmagene Laboratories Limited
Johnson & Johnson
Amersham Biosciences
Lexicon Genetics Incorporated
Athersys, Inc. Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.
Merck & Co. Diabetes
Affinimark Technologies Inc.
GlaxoSmithKline (North Carolina)
Medarex, Inc.
Gilead Sciences, Inc. (Durham, NC)
Phyton Biotech, Inc. - Cancer
Gilead Sciences, Inc. (Seattle, WA)
